Skip to main content

Surgery Partners, Inc.

For the period ended Dec 31, 2025. Filed Mar 2, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 2, 2026

SGRY$26.45+14.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SURGERY PARTNERS, INC.
By:/s/ J. Eric EvansJ. Eric EvansChief Executive Officer(Principal Executive Officer)

Date: March 2, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURESTITLEDATE
Chief Executive Officer, Director (Principal Executive Officer)March 2, 2026
/s/ J. Eric Evans
J. Eric Evans
Executive Vice President and Chief Financial Officer(Principal Financial and Accounting Officer)March 2, 2026
/s/ David T. Doherty
David T. Doherty
Chairman of the BoardMarch 2, 2026
/s/ Blair E. Hendrix
Blair E. Hendrix
DirectorMarch 2, 2026
/s/ T. Devin O'Reilly
T. Devin O'Reilly
DirectorMarch 2, 2026
/s/ Teresa DeLuca
Teresa DeLuca
DirectorMarch 2, 2026
/s/ John A. Deane
John A. Deane
DirectorMarch 2, 2026
/s/ Brent Turner
Brent Turner
DirectorMarch 2, 2026
/s/ Andrew Kaplan
Andrew Kaplan
DirectorMarch 2, 2026
/s/ Clifford G. Adlerz
Clifford G. Adlerz
DirectorMarch 2, 2026
/s/ Laura L. Forese
Laura L. Forese
DirectorMarch 2, 2026
Lloyd Dean
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.